---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-001725"
form_type: "8-K"
ticker: "PLUR"
cik: "0001158780"
company_name: "Pluri Inc."
filed_at: "2024-01-08T23:59:59+00:00"
generated_at: "2026-06-07T01:59:46.288207+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "medium"
source: SEC EDGAR
---

# Pluri launches PluriCDMO cell therapy manufacturing division led by Andy Lewin

## Summary
- New CDMO division PluriCDMO offers services from preclinical through commercialization.
- Division will be led by Andy Lewin, an experienced CDMO executive.
- Mission to deliver high-quality essential therapies; no financial guidance provided.

## SEC filing metadata
- accession: 0001213900-24-001725
- form_type: 8-K
- ticker: PLUR
- cik: 0001158780
- company_name: Pluri Inc.
- filed_at: 2024-01-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: medium
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1158780/000121390024001725/0001213900-24-001725-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1158780/000121390024001725/ea191307-8k_pluriinc.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-001725
- JSON: https://secwatch.observer/filing/0001213900-24-001725.json
- Plain text: https://secwatch.observer/filing/0001213900-24-001725.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.